Core Viewpoint - As of August 6, 2025, Innovation Medical (002173) closed at 15.88 yuan, down 2.16%, with a turnover rate of 25.49% and a trading volume of 1.0611 million hands, resulting in a transaction amount of 1.688 billion yuan [1] Group 1: Financial Performance - The company reported a main revenue of 193 million yuan for Q1 2025, a year-on-year decrease of 3.98% [3] - The net profit attributable to shareholders was -13.9374 million yuan, a year-on-year decline of 368.03% [3] - The company’s gross profit margin stood at 8.96%, significantly lower than the industry average of 34.85% [3] Group 2: Market Position and Ratios - The total market value of Innovation Medical is 7.008 billion yuan, compared to the industry average of 19.625 billion yuan, ranking 21 out of 42 in the industry [3] - The price-to-earnings ratio (P/E) is -125.7, while the industry average is 28.51 [3] - The return on equity (ROE) is -0.79%, ranking 34 out of 42 in the industry [3] Group 3: Capital Flow Analysis - On August 6, 2025, the net outflow of main funds was 165 million yuan, accounting for 9.77% of the total transaction amount [2] - Retail investors saw a net inflow of 206 million yuan, representing 12.2% of the total transaction amount [1][2] - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net inflows and outflows from different investor categories [2]
创新医疗(002173)8月6日主力资金净卖出1.65亿元